Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Sysmex's share price for the quarter that ended in Mar. 2024 was 円2661.5. Sysmex's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 623 Mil. Therefore, Sysmex's market cap for the quarter that ended in Mar. 2024 was 円1,659,443 Mil.
Sysmex's quarterly market cap
increased
from Sep. 2023 (円1,492,972 Mil) to Dec. 2023 (円1,632,859 Mil) and
increased
from Dec. 2023 (円1,632,859 Mil) to Mar. 2024 (円1,659,443 Mil).
Sysmex's annual market cap
declined
from Mar. 2022 (円1,866,782 Mil) to Mar. 2023 (円1,808,522 Mil) and
declined
from Mar. 2023 (円1,808,522 Mil) to Mar. 2024 (円1,659,443 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Sysmex's Enterprise Value for Today is 円1,692,209 Mil.
Sysmex Market Cap Historical Data
The historical data trend for Sysmex's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Sysmex's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sysmex's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sysmex's Market Cap distribution charts can be found below:
* The bar in red indicates where Sysmex's Market Cap falls into.
Sysmex Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Sysmex's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sysmex (TSE:6869) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Sysmex Market Cap Related Terms
Thank you for viewing the detailed overview of Sysmex's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Sysmex Corp manufactures and distributes in vitro diagnostic instruments, reagents, and software. The vast majority of the firm's revenue comes from selling tests for human bodily fluids to hospitals and commercial laboratories. Within this industry, the firm specializes in hematology reagents and instruments. Sysmex also sells in vitro diagnostics for applications like urinalysis and hemostasis and provides support and maintenance services for its systems. Over half of the firm's revenue is generated by sales of reagents and services, which are recurring sources of income. Sysmex primarily sells its products to customers in Japan, Europe, the Middle East, and Africa, and the Americas.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:6869 has been successfully added to your 